This would be sensible if the same MOA applied in each case. If there are different MOAs then the failure of one does not affect the probability of success of a completely different MOA.
Bisantrene is such an interesting molecule because it has multiple MOAs. This is not uncommon with old cancer drugs, but it is important to keep in mind when assessing the probability of success.
RAC
race oncology ltd
Add to My Watchlist
1.11%
!
$1.34

General Comments / Chat, page-12349
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.34 |
Change
-0.015(1.11%) |
Mkt cap ! $231.9M |
Open | High | Low | Value | Volume |
$1.35 | $1.36 | $1.31 | $132.3K | 98.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | $1.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.34 | 10069 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1849 | 1.310 |
1 | 2000 | 1.305 |
1 | 5000 | 1.290 |
3 | 21173 | 1.280 |
1 | 7843 | 1.275 |
Price($) | Vol. | No. |
---|---|---|
1.335 | 10069 | 2 |
1.385 | 2000 | 1 |
1.390 | 11231 | 2 |
1.400 | 7060 | 2 |
1.415 | 14775 | 1 |
Last trade - 15.54pm 20/06/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |